These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9973641)

  • 1. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
    Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
    Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?
    Oscier DG
    Br J Haematol; 1996 Mar; 92(3):582-6. PubMed ID: 8616021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
    Sadigh S; Hasserjian RP; Hobbs G
    Curr Opin Hematol; 2020 Mar; 27(2):122-127. PubMed ID: 31904665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
    Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
    Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic/myeloproliferative neoplasms.
    Cazzola M; Malcovati L; Invernizzi R
    Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ph-positive and -negative myeloproliferative syndromes may co-exist.
    Mauro MJ; Loriaux M; Deininger MW
    Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
    Kvasnicka HM
    Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical chronic myeloid leukemias.
    Oscier D
    Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC; Mascarenhas J
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
    Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
    Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.